Literature DB >> 2005476

HIV disease in the intravenous drug user: role of the primary care physician.

A A Wartenberg1.   

Abstract

Intravenous drug users (IVDUs) are increasingly encountered in the medical arena, on both an inpatient and an outpatient basis, in large part because of complications related to the human immunodeficiency virus (HIV). Clinicians must work to overcome long-standing antipathy towards this population in order to provide appropriate care, as well as to develop an understanding of the process of addiction and of the addict as a patient. The use of relationship skills, limit setting, and contingency contracting and an ability to choose and gain access to appropriate and/or available chemical dependency treatment options are important in the care of these patients. Finally, an adequate biomedical knowledge base of the medical complications of IVDUs, as well as the care of drug-related complications and withdrawal and overdose syndromes, is necessary to provide optimal care. In addition, the IVDU may have certain features of HIV-related disease that differ from those of other groups, and the clinician must be familiar with these features. Provision of such care is within the scope of the primary care clinician and can improve patient retention in treatment and the outcomes of such treatment, as well as both patient and clinician satisfaction.

Entities:  

Mesh:

Year:  1991        PMID: 2005476     DOI: 10.1007/bf02599256

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

Review 1.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

2.  Treatment of chronic viral hepatitis.

Authors:  S Sherlock
Journal:  J Hepatol       Date:  1988-02       Impact factor: 25.083

Review 3.  Therapeutic aspects of the clinical encounter.

Authors:  D H Novack
Journal:  J Gen Intern Med       Date:  1987 Sep-Oct       Impact factor: 5.128

4.  Treating alcohol, barbiturate, and benzodiazepine withdrawal.

Authors:  J T Sullivan; E M Seller
Journal:  Ration Drug Ther       Date:  1986-02

5.  Detoxification of alcoholics: improving care by symptom-triggered sedation.

Authors:  A A Wartenberg; T D Nirenberg; M R Liepman; L Y Silvia; A M Begin; P M Monti
Journal:  Alcohol Clin Exp Res       Date:  1990-02       Impact factor: 3.455

Review 6.  Routine immunization of the HIV-positive asymptomatic patient.

Authors:  G A Poland; K R Love; C E Hughes
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

7.  Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.

Authors:  F S Tennant; A A Sagherian
Journal:  Arch Intern Med       Date:  1987-01

8.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

9.  Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial.

Authors:  D C Drummond; D Turkington; M Z Rahman; P J Mullin; P Jackson
Journal:  Drug Alcohol Depend       Date:  1989-01       Impact factor: 4.492

10.  Taking care of the hateful patient.

Authors:  J E Groves
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

View more
  7 in total

1.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

Review 2.  Physicians and AIDS: sexual risk assessment of patients and willingness to treat HIV-infected patients.

Authors:  B Gerbert; T Bleecker; B T Maguire; N Caspers
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 3.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 4.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

5.  Management of HIV infection in patients with substance use problems.

Authors:  Ank Nijhawan; Soyun Kim; Josiah D Rich
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

6.  The ambulatory care of HIV-infected persons: a survey of physician practice patterns.

Authors:  M D Stein; P O'Sullivan; L Rubenstein; P Weller; T Wachtel
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

7.  Substance abuse and AIDS: a faculty development program for primary care providers.

Authors:  P G O'Connor; J Bigby; D Gallagher
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.